Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ipilimumab Monotherapy in Recurrent Platinum Sensitive Ovarian Cancer
NCT01611558Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Aug 2012
- Primary completion
- Nov 2014
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of ipilimumab in ovarian cancer, sponsored by Bristol Myers Squibb. Started Aug 2012; status: completed.
02
Drugs
ipilimumab
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT01611558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01611558.